spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Palatin Technologies 

 HSMN NewsFeed - 22 Feb 2022
TC Biopharm Announces Appointment of New Board Members
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Jun 2021
Palatin Announces New Additions to Its Senior Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jun 2019
Palatin Technologies Granted FDA Orphan Drug Designation -- PL-8177 for the Treatment of Non-Infectious Uveitis
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 10 Apr 2017
Non-Opioid Drug Development Firm, CerSci Therapeutics, Announces Appointment of Pharma Leaders Pat Confalone and Perry Molinoff to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Feb 2017
Palatin Technologies Announces Closing of License Agreement with AMAG Pharmaceuticals for North American Rights to Rekynda(TM)
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 4 Feb 2016
Lion Biotechnologies Names Steven A. Fischkoff Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Dec 2015
Derma Sciences Announces Leadership and CEO Transition
Devices Regenerative Medicine Wound Care Personnel
 HSMN NewsFeed - 28 Apr 2014
Actinium Announces Key Additions to Senior Management Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Sep 2013
Actinium Pharmaceuticals Appoints Kaushik J. Dave, Ph.D., MBA As President, Chief Executive Officer And Director
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Dec 2010
Sutro Biopharma Appoints Trevor Hallam, Ph.D., as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Nov 2010
Palatin Technologies Appoints Jeffrey D. Edelson, M.D., Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jan 2010
Adolor Corporation Announces Management Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jan 2008
Palatin Technologies Announces Litigation Settlement With Competitive Technologies
Biopharmaceuticals Licensing Litigation
 HSMN NewsFeed - 26 Sep 2007
Palatin Technologies Announces Reduction of Workforce
Biopharmaceuticals
 HSMN NewsFeed - 30 Aug 2007
King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
Biopharmaceuticals
 HSMN NewsFeed - 21 May 2007
Intercept Pharmaceuticals Expands Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Dec 2006
Palatin Technologies and King Pharmaceuticals Complete Enrollment in Pre-Menopausal Cohort of a Phase 2 Clinical Trial Evaluating Bremelanotide in Pre- and Post-Menopausal Female Sexual Dysfunction Patients
Biopharmaceuticals
 HSMN NewsFeed - 6 Nov 2006
Palatin Technologies and King Pharmaceuticals Report Results For Two Phase 2B Clinical Trials Evaluating Bremelanotide in Male Erectile Dysfunction Patients
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 23

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 23 additional stories matching:
Palatin Technologies
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.